Final Rules Issued for Health Care Reform Tax on Medical Devices, Effective January 1, 2013

by Ballard Spahr LLP
Contact

[authors: Jean C. Hemphill, Laura A. Kowal]

The Internal Revenue Service (IRS) released final regulations and other guidance on the excise tax applicable to the sale of certain medical devices under the Affordable Care Act. Beginning January 1, 2013, a tax of 2.3 percent is imposed on the sale, use, lease, or license of all medical devices by manufacturers and importers.

In the guidance, the IRS has confirmed that most types of medical devices intended for humans are subject to the excise tax. Medical devices purchased by the general public at retail businesses for individual use and the sales of taxable medical devices for further manufacture or export are not subject to the tax. The IRS also issued interim guidance and requested comments on methods for determining the constructive sales price of a medical device, the taxation of donated medical devices, whether the licensing of medical devices (such as software) is taxable, and the tax treatment of medical convenience kits.

Taxable Medical Devices

As proposed, the IRS confirmed that the tax applies to all devices listed with the Food and Drug Administration (FDA) under the applicable section of the Federal Food, Drug and Cosmetic Act (FD&C Act) and the applicable federal regulations, as well as devices that should have been listed with the FDA, including:

  • Biologics (not including any biologics that are not listed with the FDA under the FD&C Act, but are regulated by the Center for Biologics Evaluation and Research, such as those listed under regulations that apply to manufacturers of human blood and blood products)
  • Sterilization process indicators, software, and containers used to hold or transport medical products and specimens
  • Devices that are not used exclusively for humans (i.e., also intended for veterinary use)
  • Devices that are not sold exclusively for medical use (i.e., devices not intended solely for medical purposes)
  • Humanitarian use devices
  • Combined products (therapeutic and diagnostic products that combine drugs, devices, and/or biologic products)

Kits produced by hospitals and medical institutions are exempt from the FDA registration and listing requirements and are not subject to the tax, but sales of the individual medical devices in the kits by the manufacturers to the kit producers are subject to the tax.

Exception for Medical Devices Sold at Retail

The tax does not apply to medical devices that are regularly available for purchase by individual consumers, in person, over the telephone or over the Internet through retail businesses, and that are not primarily intended for use by medical professionals or facilities. These devices include eyeglasses, contact lenses, and hearing aids. The regulations adopt a “facts and circumstances” approach to determining whether a medical device falls within the retail exception, and they include a non-exclusive list of factors to determine whether a device is regularly available for purchase by consumers who are not medical professionals.

The regulations also include a safe harbor provision that identifies certain categories of medical devices that meet the retail exception, including: over-the-counter home use lab tests; durable medical equipment and prosthetic and orthotic devices for which payment is available under Medicare Part B and do not require implantation or insertion by a medical professional; parenteral and enteral nutrients, equipment, and supplies; customized items as described in regulations for devices covered by Medicare Part B payments, such as orthotics; therapeutic shoes; and certain supplies for the effective use of durable medical equipment. Examples illustrating the application of the rule are included in the final regulation.

Other Exceptions from Tax

In addition to those medical devices that are not listed with the FDA, the final regulations provide a few other exceptions from the tax:

  • The sale of software that is a component of a listed medical device and updates to component software, which are not required to be separately listed
  • Donations of listed devices to an eligible donor

Additionally, in the event listed software is sold together with a service or maintenance contract, the tax only applies to that portion of the sales price allocated to the listed software.

The regulations do not provide any transition relief for contracts entered into before January 1, 2013, unless the contract was entered into before March 30, 2010. Payments made on or after January 1, 2013, pursuant to a written contract for the lease, installment sale, or sale on credit of a taxable medical device that were in effect prior to March 30, 2010, are not subject to the tax unless the contract was materially modified to change the product being sold or leased, or the payment terms.

Determining the Sale Price

The IRS announced interim rules on determining the constructive sale price in acknowledgement of the differing distribution chains regularly employed in the medical device industry. The rules set a range of percentages (depending on the distribution chain) based on the lowest actual selling price as the constructive sale price for purposes of the tax if the purchaser is a reseller other than an independent wholesale distributor. A taxpayer may use the rules, the actual sale price, or its own determination of the fair market value to calculate its tax liability. A manufacturer may take into account a rebate in determining the sale price, but only to the extent that the rebate is made before the close of the quarter during which the sale associated with the rebate is made.

Tax Reporting

The medical device excise tax is reported quarterly on Form 720, and to make tax-free sales, the manufacturer must register using Form 637. Each business unit with a separate tax identification number (even a disregarded entity) must file its own return or registration form and may not consolidate the tax reporting with affiliated corporations. Semi-monthly deposits of the tax are required unless the net tax liability does not exceed $2,500 for the quarter. As the federal health care reform effort gained steam, Ballard Spahr attorneys launched the Health Care Reform Initiative to monitor and analyze legislative developments. With federal health care reform now a reality, out attorneys are assisting health care entities and employers in understanding the relevant changes and planning for the future. If you have questions about the Affordable Care Act’s impact on the taxation of medical devices or any other implications of the law, contact Jean C. Hemphill at 215.864.8539 or hemphill@ballardspahr.com, or Laura A. Kowal at 215.864.8472 or kowall@ballardspahr.com.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ballard Spahr LLP | Attorney Advertising

Written by:

Ballard Spahr LLP
Contact
more
less

Ballard Spahr LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.